… cellular and humoral immune changes induced by SARS-CoV-2 and to propose the possibility
… the immunotherapeutic approach is of fundamental importance for SARS-CoV-2 infection. …

… SARS CoV, Middle East respiratory syndrome related coronavirus (MERS CoV), and other
coronavirus vaccines revealed several safety concerns associated with the use of coronavirus …

… Pronounced Tim-3 expression was discovered on the cell surface of T cells by flow …
advanced malignant melanoma treated with immunotherapy was meaningfully lower as compared …

… immunosuppression and immunotherapy among cancer patients … In this study, immunotherapy
included immune checkpoint … immunotherapy agents. CAR T-cell and BiTE therapies are …

… The first mAb approved in clinical practice was Muromonab-CD3 (OKT3) in 1986, which was
the milestone of immunotherapy. Since then, advanced antibody discovery and engineering …

… Discovery of Anti-ACE2 Peptides Using Phage Biopanning In this study, we aim to discover
an anti-ACE2 peptide that can block the SARS-CoV-… , which can discover small peptides that …

… A 5% anti-COVID-19 IVIG solution contains 90% immunoglobulins (IgG, IgM and IgA),
and the total anti-SARS CoV-2 antibody titre is three times higher than pooled convalescent …

The emergence of a new acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2), the
cause of the 2019‐nCOV disease (COVID‐19), has caused a pandemic and a global health …

… Throughout this pandemic, the zoonotic SARS-CoV-2 has … epidemiological situation of
emerging SARS CoV-2 variants and … acquired by the evolving SARS CoV-2 virus accounting for …

… Citation198 indicated that hMS-1 might be developed as an effective immunotherapeutic …
Citation266 discovered that SARS and MERS and SARS-CoV-2 infection is enhanced by …